3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
4
Completed
3
Active not recruiting
2
Unknown
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Gastrointestinal
1
Breast
1
Conditions
Esophageal Neoplasms
1
Cardiotoxicity
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Oxaliplatin
86
Bevacizumab
66
Capecitabine
65
Fluorouracil
48
tislelizumab
41
Gemcitabine
40
Drug Therapy
39
Leucovorin
38
sintilimab
35
Irinotecan
34
lenvatinib
27
Cisplatin
27
HMPL-013
25
S 1 (combination)
23
camrelizumab
22
Immune Checkpoint Inhibitors
21
irinotecan sucrosofate
20
apatinib
20
Surgical Procedures, Operative
20
Radiotherapy
20
Injections
20
130-nm albumin-bound paclitaxel
20
toripalimab
19
Paclitaxel
18
Folfox protocol
17
pembrolizumab
15
Immunotherapy
15
Cetuximab
15
Specimen Handling
14
regorafenib
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Diagnostic Imaging
×
Gastrointestinal
×
Clear all
NCT06986291
2025-05-29
CorTox
Technische Universität Dresden
Phase NA
Not yet recruiting
325 enrolled